Skip to main content

Table 5 Adjusted mean change of SUA level from baseline to exposure period

From: Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study

ARB

Mean

95% CI

p value

vs Losartan

vs Valsartan

vs Telmisartan

vs Candesartan

ΔLosartan

-0.124

(-0.243, -0.0055)

-

-

-

-

ΔValsartan

0.186

(0.0824, 0.289)

0.0012*

-

-

-

ΔTelmisartan

0.150

(0.0239, 0.275)

0.0172*

0.9926

-

-

ΔCandesartan

0.153

(0.0755, 0.231)

0.0013*

0.9884

1

-

ΔOlmesartan

0.166

(0.0413, 0.290)

0.0089*

0.9992

0.9998

0.9998

  1. ARB, Angiotensin II type I receptor blocker; CI, Confidence interval. Δ: mean change in SUA level during exposure period from baseline. *: p < 0.05 (p value among ARBs, Tukey’s post-hoc analysis). Analyses were adjusted for covariates including age, sex, medical history and previous medication.